Ticker Details
Marker Therapeutics, Inc.
IPO Date:	August 1, 2002
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$24.18M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.12 | 4.35%
Avg Daily Range (30 D):	$0.09 | 5.19%
Avg Daily Range (90 D):	$0.06 | 4.30%

Institutional Daily Volume
Avg Daily Volume:	.2M
Avg Daily Volume (30 D):	.35M
Avg Daily Volume (90 D):	.31M

Trade Size
Avg Trade Size (Sh.):	115
Avg Trade Size (Sh.) (30 D):	335
Avg Trade Size (Sh.) (90 D):	358

Institutional Trades
Total Institutional Trades:	24
Avg Institutional Trade:	$2.18M
Avg Institutional Trade (30 D):	$.92M
Avg Institutional Trade (90 D):	$.92M
Avg Institutional Trade Volume:	.06M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$5.02M
Avg Closing Trade (30 D):	$M
Avg Closing Trade (90 D):	$M
Avg Closing Volume:	106.23K

News

Aug 28, 2025 @ 12:00 PM Marker Therapeutics to Participate in a Fireside C... Source: Marker Therapeutics, Inc.

Aug 26, 2025 @ 11:00 AM Marker Therapeutics Provides Update on Phase 1 APO... Source: Marker Therapeutics

Jun 17, 2025 @ 12:00 PM Marker Therapeutics and Cellipont Bioservices Anno... Source: N/A

Nov 26, 2024 @ 4:00 PM Marker Therapeutics to Present at the Citizens JMP... Source: N/A

May 15, 2024 @ 8:15 PM Marker Therapeutics Reports First Quarter 2024 Fin... Source: Marker Therapeutics

Financials
	TTM	Q2 2025	Q1 2025
Basic EPS	$-.12	$-.29	$-.4
Diluted EPS	$-.12	$-.29	$-.4
Revenue	$1.23M	$.86M	$.35M
Gross Profit
Net Income / Loss	$-2M	$-4.02M	$-4.45M
Operating Income / Loss	$-2.14M	$-4.26M	$-4.61M
Cost of Revenue
Net Cash Flow	$M	$M	$M
PE Ratio

Splits
Jan 27, 2023	1:10
Sep 16, 2016	1:12
Feb 25, 2014	1:100
Jul 27, 2009	1:10
Jun 28, 2007	2:5
Jun 08, 2001	1:50